Developer docs
API playgroundTry for free, no card

Search company profiles

Ozyme

Full company profile

uuid002drt1

Namestring
Ozyme
Legal namestring
OZYME SAS
Websiteurl
yris.ozyme.fr
Company typeenum
Private
Founded yearint
1984
Descriptiontext

Ozyme SAS is a French specialty distributor of laboratory products for research, operating since 1984 from Saint-Cyr-l'École near Paris. The company aggregates a catalog of more than 10,000 SKUs across cell biology, immunology, and molecular biology, sourced from roughly 20 international manufacturers including Corning (cell culture), Cell Signaling Technology, Bethyl Laboratories, Jackson ImmunoResearch, and Leinco Technologies (antibodies), Lexogen, Navinci, Codex DNA and Bio-Works (molecular biology), as well as newer 2025-vintage partners Standard BioTools (Biomark X9), ACEPIX (IHC/spatial biology), AOPIA Biosciences (NANOEX extracellular vesicle system), and Illumina (MiSeq i100 NGS sequencers, partnership announced April 2026). In September 2025 Ozyme launched its first proprietary private-label line, OWIBIO, a range of bioreagents for PCR/qPCR/West blot co-developed with parent Dominique Dutscher. Earlier proprietary or featured items include the EVE PLUS automatic cell counter, EXTRANSFECTION electroporation pipette system, and refurbished equipment trade-ins.

The business is sales-led, combining an e-commerce storefront (yris.ozyme.fr), a direct sales team, and an inside-sales/customer-service desk handling availability, pricing, quotes, and French public procurement. Roughly half of the ~40-employee team hold 3rd-cycle university or engineering-school scientific credentials, and the company claims 80% of technical questions are answered without delay and 24-hour express delivery for in-stock items. Revenue is generated through unit, kit, and equipment sales with quote-based pricing; no subscription model is offered. Ozyme was acquired by Dominique Dutscher, a French life sciences distribution group, in May 2023, and continues to operate under the Ozyme brand serving research laboratories exclusively in France.

Customer profiles and named logos are not disclosed in available materials; based on product mix (antibodies, NGS reagents, qPCR systems, cell culture, IHC, EV isolation) and French-language public-procurement handling, end users are predominantly academic, hospital, biotech, and CRO research laboratories. Marketing reaches these buyers via a monthly newsletter (INFOZYME), technical letters (TechOzyme), social channels (LinkedIn, Facebook, Instagram, YouTube), scientific congresses, webinars, and product video tutorials. No AI, machine learning, public APIs, mobile apps, patents, or external funding rounds are disclosed, and revenue is not publicly reported.

Short descriptiontext

Ozyme is a French laboratory products distributor serving research laboratories in France since 1984, specializing in cell biology, immunology, and molecular biology reagents, equipment, and consumables sourced from major international brands.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersSaint-cyr-l'ecole, France
HQ citystring
Saint-cyr-l'ecole
HQ countrystring
France
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
laboratory supplies distribution, antibody reagent supply, molecular biology reagents, cell culture consumables, research laboratory equipment
NAICS code1 code
  • Miscellaneous Durable Goods Merchant Wholesalers4239
SIC code2 codes
  • Wholesale-Chemicals & Allied Products5160
  • Wholesale-Machinery, Equipment & Supplies5080
Product category
Life sciences research supplies distribution
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Laboratory Products Distribution
TypeHardware Sales
Description

Revenue generated from distributing laboratory products including antibodies, molecular biology reagents, cell culture supplies, consumables, and laboratory equipment from various brand partners to research laboratories in France.

yris.ozyme.fr
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Supply Chain, Operations, Marketing or Sales, Technology or R&D, Infrastructure
Pricing details1 tier
1Various laboratory products with unit-based pricing
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Products priced per unit, kit, or µl. Example: antibody products range from 4.84€ to 507€ depending on format and size.

yris.ozyme.fr
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 record
1OWIBIO
Description

A brand of bioréactifs (bioreagents) for molecular biology applications including PCR (routine, hot start, high fidelity), RT & qPCR, electrophoresis, and Western blot. Developed in collaboration with Dutscher.

yris.ozyme.fr
Core offering1 text field

Ozyme is a specialty distributor of laboratory products for life sciences research in France, supplying research laboratories with antibodies, molecular biology reagents, cell culture consumables, and laboratory equipment sourced from leading manufacturers such as Cell Signaling Technology, Illumina, Corning, and Standard BioTools. The company offers its own OWIBIO molecular biology bioreagent line and provides technical support, 24-hour express delivery, equipment installation, and maintenance services alongside product sales.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • Technical service answering 80% of questions without delay
+1 more record
Product overview1 text field

Ozyme is a specialized laboratory products distributor serving the French research market since 1984, offering a comprehensive portfolio of products across cell biology, immunology, and molecular biology. The company operates as a multi-brand distributor, aggregating products from major international manufacturers (Cell Signaling Technology, Illumina, Standard BioTools, Corning, and others) alongside proprietary offerings. Key branded products include the OWIBIO molecular biology reagent line, NANOEX™ automated extracellular vesicle purification system, EVE™ PLUS automatic cell counters, EXTRANSFECTION™ electroporation devices, and PhosphoPlus® Antibody Duets from Cell Signaling Technology. Ozyme also distributes Illumina sequencing systems (MiSeq i100 series), Standard BioTools' Biomark X9 microfluidic qPCR platform, and ACEPIX tissue analysis solutions. The company provides equipment installation and support services alongside product sales, targeting research laboratories in France with a team of technically-trained scientific staff.

Product and service10 records
1Antibodies (Primary and Secondary)
CategoryAntibodies
2Molecular Biology Reagents
CategoryMolecular Biology Reagents
3Cell Culture and Analysis Products
CategoryCell Culture Products
4Laboratory Equipment
CategoryLaboratory Equipment
5OWIBIO Bioréactifs Molecular Biology Range
CategoryMolecular Biology Reagents
6NANOEX Extracellular Vesicle Purification System
CategoryExtracellular Vesicle Purification
7EVE PLUS Automatic Cell Counter
CategoryCell Counting Equipment
8EXTRANSFECTION Electroporation System
CategoryElectroporation Equipment
9PhosphoPlus Antibody Duets
CategoryAntibody Kits
10Illumina MiSeq i100 and i100 Plus Sequencers
CategoryDNA Sequencers
Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership16 partners
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2026-04-01
Description

New collaboration between Ozyme and Illumina, world leader in DNA sequencing (NGS). This collaboration aims to combine Ozyme's expertise and Illumina's advanced sequencing technologies to facilitate laboratories' access to sequencing solutions. The common goal is to make genome study simpler and more accessible for all.

2OWIBIO (Dutscher)
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2025-09-01
Description

Launch of OWIBIO bioréactifs product line for molecular biology applications. Result of tight scientific collaboration between Ozyme and Dutscher, offering reliable and accessible solutions at the right price combining scientific expertise and field proximity.

yris.ozyme.fr
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2025-07-01
Description

Partnership with AOPIA Biosciences, expert in innovative extracellular vesicle (EV) purification technologies used in biomedical research and cosmetics. This collaboration allows Ozyme to offer cutting-edge solutions for EV isolation, meeting growing needs for quality, reproducibility, and performance.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2025-06-01
Description

Partnership enriching Ozyme's genomics portfolio with Standard BioTools' Biomark X9 platform, a high-throughput automated microfluidic qPCR solution. This collaboration brings cutting-edge technology to multiply analysis capabilities while optimizing sample and reagent consumption.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2025-04-01
Description

Partnership strengthening Ozyme's immunohistochemistry (IHC) and spatial biology offerings with ACEPIX's advanced tissue analysis solutions. This collaboration enriches and perfectly complements their IHC portfolio with innovative technologies for improved precision, reproducibility, and efficiency.

6Dominique Dutscher
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2023-05-01
Description

Dutscher group acquisition of Ozyme in France, strengthening their presence in Life Sciences sector in France.

yris.ozyme.fr
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2022-10-01
Description

Partnership expanding portfolio with Leinco Technologies' solutions, recognized specialist in antibodies, recombinant proteins, and research reagents including functional in vivo antibodies. Strengthens cell biology and immunology offerings.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2022-09-01
Description

Partnership with ISO 9001 certified Swedish company developing protein purification resins for research laboratories and large-scale bioproduction. WorkBeads™ agarose-based next-generation resins for purifying histidine-tagged proteins, antibodies, peptides, and other biomolecules.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2022-06-01
Description

Partnership adding Slingshot's synthetic cell solutions for flow cytometry calibration and compensation. Products include SpectraCom® for spectral/conventional cytometry, ViaComp® for viability markers, FlowCyte® for instrument calibration, and TruCytes® with biomarker-incorporating synthetic cells.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2022-01-01
Description

Partnership adding Navinci's Proximity Ligation platform technology for analyzing and quantifying proteins at molecular level in natural cellular environment. Applications include immuno-profiling, signaling, drug screening, and biomarker discovery.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2021-10-01
Description

Partnership with Austrian company specializing in transcriptome profiling solutions and NGS data analysis. Key technologies include QuantSeq 3' mRNA-Seq Library Prep, RiboCop rRNA Depletion, and CORALL Total RNA-Seq Library Prep.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2020-12-01
Description

Partnership adding Codex DNA's synthetic gene production solutions including Gibson Assembly® kits (co-founded by Dan Gibson, inventor of Gibson cloning technology) and Vmax™ competent cells for protein production in bacteria.

Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2019-09-01
Description

JIR, American company with 35+ years specializing in secondary antibody production and purification. Products include secondary antibodies conjugated with fluorophores, enzymes (HRP, PA), or gold beads for IF, FC, IHC, ELISA, WB, and electron microscopy applications.

Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2019-04-01
Description

Partnership with Corning for cell culture products, leveraging 160 years of innovation and excellence. Complete portfolio of high-quality cell culture media and consumables from a recognized R&D expert in life sciences.

15Azure Biosystems
Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2018-06-01
Description

Partnership for gel and Western blot imagers and scanners. Products include cSeries imagers for chemiluminescence and fluorescence detection, and Sapphire™ scanners combining phosphorimaging, fluorescence, and chemiluminescence capabilities.

yris.ozyme.fr
16Bethyl Laboratories
Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2018-03-01
Description

Partnership adding Bethyl Laboratories' antibody catalog with over 19,000 antibody references for WB, IP, ELISA, and IHC in cancer, cardiovascular, cell biology, immunology, neurobiology, and signal transduction fields.

yris.ozyme.fr
Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
1Tebu-bio
TypeDirect peer
Description

European distributor of life science research reagents and instruments, active in France through Tebu-bio SAS. Overlaps with Ozyme in antibody, cell biology, and molecular biology distribution to French and Benelux research labs.

TypeBroad incumbent
Description

Global antibody specialist (now part of Danaher) with a 100,000+ product catalog and direct e-commerce/distribution in France. Direct overlap with Ozyme's primary and secondary antibody business, with primary antibodies representing a core Ozyme category.

TypeRegional player
Description

French life sciences distributor of reagents, antibodies, and cell biology products for research and clinical markets. Comparable business model and customer base to Ozyme, focused on the French-speaking research community.

TypeBroad incumbent
Description

Global life sciences company with deep catalog of reagents (antibodies, proteins, ELISA kits, cell/gene therapy tools) and direct sales across Europe, including France. Competes with Ozyme in antibody and protein reagent distribution but at much larger scale and with proprietary products (R&D Systems, Novus, Tocris).

TypeBroad incumbent
Description

Global life science arm of Merck KGaA distributing reagents, antibodies, lab consumables, and bioprocessing products with significant direct presence in France. Overlaps with Ozyme's molecular biology, cell culture, and antibody offerings but operates at much larger scale with proprietary product lines.

TypeEmerging player
Description

US-based antibody and reagent developer that Ozyme distributes in France. Comparable as a specialized antibody supplier with strong presence in signaling pathway research; an upstream supplier to Ozyme but also a competitor when end users buy direct.

TypeBroad incumbent
Description

Largest global life sciences tools and reagents provider with direct sales and distribution of antibodies, molecular biology reagents, cell culture, and lab equipment across France. Competes with Ozyme across nearly every category but as part of a much broader portfolio.

TypeDirect peer
Description

German specialty distributor of chemicals, reagents, and consumables for life science and analytical laboratories across Europe. Comparable as a multi-brand European lab products specialist with strong own-label portfolio (Roti, Rotipuran) serving research customers.

9Dominique Dutscher
TypeDirect peer
Description

French life sciences distribution group and parent of Ozyme since May 2023. Operates an overlapping multi-brand catalog of laboratory consumables, reagents, and equipment across France with comparable customer base (research labs, biotech, pharma). Most directly comparable peer given the ownership and product overlap.

TypeBroad incumbent
Description

Global laboratory products and services distributor (formerly VWR) serving research, pharma, and academic customers across Europe, including France. Comparable distribution model and customer base but vastly broader catalog spanning chemicals, consumables, equipment, and life sciences.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Ozyme

Life sciences research supplies distributionyris.ozyme.fr

Ozyme is a French laboratory products distributor serving research laboratories in France since 1984, specializing in cell biology, immunology, and molecular biology reagents, equipment, and consumables sourced from major international brands.

What Ozyme does

Ozyme SAS is a French specialty distributor of laboratory products for research, operating since 1984 from Saint-Cyr-l'École near Paris. The company aggregates a catalog of more than 10,000 SKUs across cell biology, immunology, and molecular biology, sourced from roughly 20 international manufacturers including Corning (cell culture), Cell Signaling Technology, Bethyl Laboratories, Jackson ImmunoResearch, and Leinco Technologies (antibodies), Lexogen, Navinci, Codex DNA and Bio-Works (molecular biology), as well as newer 2025-vintage partners Standard BioTools (Biomark X9), ACEPIX (IHC/spatial biology), AOPIA Biosciences (NANOEX extracellular vesicle system), and Illumina (MiSeq i100 NGS sequencers, partnership announced April 2026). In September 2025 Ozyme launched its first proprietary private-label line, OWIBIO, a range of bioreagents for PCR/qPCR/West blot co-developed with parent Dominique Dutscher. Earlier proprietary or featured items include the EVE PLUS automatic cell counter, EXTRANSFECTION electroporation pipette system, and refurbished equipment trade-ins.

The business is sales-led, combining an e-commerce storefront (yris.ozyme.fr), a direct sales team, and an inside-sales/customer-service desk handling availability, pricing, quotes, and French public procurement. Roughly half of the ~40-employee team hold 3rd-cycle university or engineering-school scientific credentials, and the company claims 80% of technical questions are answered without delay and 24-hour express delivery for in-stock items. Revenue is generated through unit, kit, and equipment sales with quote-based pricing; no subscription model is offered. Ozyme was acquired by Dominique Dutscher, a French life sciences distribution group, in May 2023, and continues to operate under the Ozyme brand serving research laboratories exclusively in France.

Customer profiles and named logos are not disclosed in available materials; based on product mix (antibodies, NGS reagents, qPCR systems, cell culture, IHC, EV isolation) and French-language public-procurement handling, end users are predominantly academic, hospital, biotech, and CRO research laboratories. Marketing reaches these buyers via a monthly newsletter (INFOZYME), technical letters (TechOzyme), social channels (LinkedIn, Facebook, Instagram, YouTube), scientific congresses, webinars, and product video tutorials. No AI, machine learning, public APIs, mobile apps, patents, or external funding rounds are disclosed, and revenue is not publicly reported.

Ozyme firmographics

Firmographics
Name
Ozyme
Legal name
OZYME SAS
Website
https://yris.ozyme.fr
Company type
Private
Founded year
1984
Operating status
Operating
Headcount range
11–50 employees
Short description
Ozyme is a French laboratory products distributor serving research laboratories in France since 1984, specializing in cell biology, immunology, and molecular biology reagents, equipment, and consumables sourced from major international brands.
Ownership category
akta.pro rank

Where Ozyme is headquartered

Location

Headquarters

HQ city
Saint-cyr-l'ecole
HQ country
France
HQ region
Europe

Offices1 record

Markets served

Ozyme business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Supply Chain, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

  1. Laboratory Products Distribution: Revenue generated from distributing laboratory products including antibodies, molecular biology reagents, cell culture supplies, consumables, and laboratory equipment from various brand partners to research laboratories in France.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goVarious laboratory products with unit-based pricing

Go-to-market motion1 record

Distribution channels3 records

Marketing channels7 records

Ozyme product offering

Product offering

Core offering

Ozyme is a specialty distributor of laboratory products for life sciences research in France, supplying research laboratories with antibodies, molecular biology reagents, cell culture consumables, and laboratory equipment sourced from leading manufacturers such as Cell Signaling Technology, Illumina, Corning, and Standard BioTools. The company offers its own OWIBIO molecular biology bioreagent line and provides technical support, 24-hour express delivery, equipment installation, and maintenance services alongside product sales.

Product overview

Ozyme is a specialized laboratory products distributor serving the French research market since 1984, offering a comprehensive portfolio of products across cell biology, immunology, and molecular biology. The company operates as a multi-brand distributor, aggregating products from major international manufacturers (Cell Signaling Technology, Illumina, Standard BioTools, Corning, and others) alongside proprietary offerings. Key branded products include the OWIBIO molecular biology reagent line, NANOEX™ automated extracellular vesicle purification system, EVE™ PLUS automatic cell counters, EXTRANSFECTION™ electroporation devices, and PhosphoPlus® Antibody Duets from Cell Signaling Technology. Ozyme also distributes Illumina sequencing systems (MiSeq i100 series), Standard BioTools' Biomark X9 microfluidic qPCR platform, and ACEPIX tissue analysis solutions. The company provides equipment installation and support services alongside product sales, targeting research laboratories in France with a team of technically-trained scientific staff.

Differentiator

Problem solved

Functional benefit

Brands

  • OWIBIO: A brand of bioréactifs (bioreagents) for molecular biology applications including PCR (routine, hot start, high fidelity), RT & qPCR, electrophoresis, and Western blot. Developed in collaboration with Dutscher.

Products and services

  • Antibodies (Primary and Secondary)
  • Molecular Biology Reagents
  • Cell Culture and Analysis Products
  • Laboratory Equipment
  • OWIBIO Bioréactifs Molecular Biology Range
  • NANOEX Extracellular Vesicle Purification System
  • EVE PLUS Automatic Cell Counter
  • EXTRANSFECTION Electroporation System
  • PhosphoPlus Antibody Duets
  • Illumina MiSeq i100 and i100 Plus Sequencers

Quantifiable outcome

  • Technical service answering 80% of questions without delay
  • +1 more outcomes

Companies that use Ozyme

Customer profile

Segments1 record

Ideal customer profiles1 record

Ozyme technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Ozyme partnerships and signals

Strategic signal

Partnerships

16 partnerships are on record, tiered core.

  • IlluminacoreTechnology or Integration · 1 April 2026New collaboration between Ozyme and Illumina, world leader in DNA sequencing (NGS). This collaboration aims to combine Ozyme's expertise and Illumina's advanced sequencing technologies to facilitate laboratories' access to sequencing solutions. The common goal is to make genome study simpler and more accessible for all.
  • OWIBIO (Dutscher)coreTechnology or Integration · 1 September 2025Launch of OWIBIO bioréactifs product line for molecular biology applications. Result of tight scientific collaboration between Ozyme and Dutscher, offering reliable and accessible solutions at the right price combining scientific expertise and field proximity.
  • AOPIA BiosciencescoreTechnology or Integration · 1 July 2025Partnership with AOPIA Biosciences, expert in innovative extracellular vesicle (EV) purification technologies used in biomedical research and cosmetics. This collaboration allows Ozyme to offer cutting-edge solutions for EV isolation, meeting growing needs for quality, reproducibility, and performance.
  • Standard BioToolscoreTechnology or Integration · 1 June 2025Partnership enriching Ozyme's genomics portfolio with Standard BioTools' Biomark X9 platform, a high-throughput automated microfluidic qPCR solution. This collaboration brings cutting-edge technology to multiply analysis capabilities while optimizing sample and reagent consumption.
  • ACEPIX BiosciencescoreTechnology or Integration · 1 April 2025Partnership strengthening Ozyme's immunohistochemistry (IHC) and spatial biology offerings with ACEPIX's advanced tissue analysis solutions. This collaboration enriches and perfectly complements their IHC portfolio with innovative technologies for improved precision, reproducibility, and efficiency.
  • Dominique DutschercoreStrategic or Co-development Partner · 1 May 2023Dutscher group acquisition of Ozyme in France, strengthening their presence in Life Sciences sector in France.
  • Leinco TechnologiescoreTechnology or Integration · 1 October 2022Partnership expanding portfolio with Leinco Technologies' solutions, recognized specialist in antibodies, recombinant proteins, and research reagents including functional in vivo antibodies. Strengthens cell biology and immunology offerings.
  • Bio-WorkscoreTechnology or Integration · 1 September 2022Partnership with ISO 9001 certified Swedish company developing protein purification resins for research laboratories and large-scale bioproduction. WorkBeads™ agarose-based next-generation resins for purifying histidine-tagged proteins, antibodies, peptides, and other biomolecules.
  • SlingshotcoreTechnology or Integration · 1 June 2022Partnership adding Slingshot's synthetic cell solutions for flow cytometry calibration and compensation. Products include SpectraCom® for spectral/conventional cytometry, ViaComp® for viability markers, FlowCyte® for instrument calibration, and TruCytes® with biomarker-incorporating synthetic cells.
  • NavincicoreTechnology or Integration · 1 January 2022Partnership adding Navinci's Proximity Ligation platform technology for analyzing and quantifying proteins at molecular level in natural cellular environment. Applications include immuno-profiling, signaling, drug screening, and biomarker discovery.
  • LexogencoreTechnology or Integration · 1 October 2021Partnership with Austrian company specializing in transcriptome profiling solutions and NGS data analysis. Key technologies include QuantSeq 3' mRNA-Seq Library Prep, RiboCop rRNA Depletion, and CORALL Total RNA-Seq Library Prep.
  • Codex DNAcoreTechnology or Integration · 1 December 2020Partnership adding Codex DNA's synthetic gene production solutions including Gibson Assembly® kits (co-founded by Dan Gibson, inventor of Gibson cloning technology) and Vmax™ competent cells for protein production in bacteria.
  • Jackson Immuno Research (JIR)coreChannel Partner/ Reseller/ Distributor · 1 September 2019JIR, American company with 35+ years specializing in secondary antibody production and purification. Products include secondary antibodies conjugated with fluorophores, enzymes (HRP, PA), or gold beads for IF, FC, IHC, ELISA, WB, and electron microscopy applications.
  • CorningcoreChannel Partner/ Reseller/ Distributor · 1 April 2019Partnership with Corning for cell culture products, leveraging 160 years of innovation and excellence. Complete portfolio of high-quality cell culture media and consumables from a recognized R&D expert in life sciences.
  • Azure BiosystemscoreChannel Partner/ Reseller/ Distributor · 1 June 2018Partnership for gel and Western blot imagers and scanners. Products include cSeries imagers for chemiluminescence and fluorescence detection, and Sapphire™ scanners combining phosphorimaging, fluorescence, and chemiluminescence capabilities.
  • Bethyl LaboratoriescoreChannel Partner/ Reseller/ Distributor · 1 March 2018Partnership adding Bethyl Laboratories' antibody catalog with over 19,000 antibody references for WB, IP, ELISA, and IHC in cancer, cardiovascular, cell biology, immunology, neurobiology, and signal transduction fields.

Scale indicators5 records

Recent moves7 records

Expansion highlights5 records

Ozyme competitors and assessment

Company assessment

Direct peers

  • Tebu-bio: European distributor of life science research reagents and instruments, active in France through Tebu-bio SAS. Overlaps with Ozyme in antibody, cell biology, and molecular biology distribution to French and Benelux research labs.
  • Carl Roth: German specialty distributor of chemicals, reagents, and consumables for life science and analytical laboratories across Europe. Comparable as a multi-brand European lab products specialist with strong own-label portfolio (Roti, Rotipuran) serving research customers.
  • Dominique Dutscher: French life sciences distribution group and parent of Ozyme since May 2023. Operates an overlapping multi-brand catalog of laboratory consumables, reagents, and equipment across France with comparable customer base (research labs, biotech, pharma). Most directly comparable peer given the ownership and product overlap.

Broad incumbents

  • Abcam (Danaher): Global antibody specialist (now part of Danaher) with a 100,000+ product catalog and direct e-commerce/distribution in France. Direct overlap with Ozyme's primary and secondary antibody business, with primary antibodies representing a core Ozyme category.
  • Bio-Techne: Global life sciences company with deep catalog of reagents (antibodies, proteins, ELISA kits, cell/gene therapy tools) and direct sales across Europe, including France. Competes with Ozyme in antibody and protein reagent distribution but at much larger scale and with proprietary products (R&D Systems, Novus, Tocris).
  • Merck Life Science (MilliporeSigma): Global life science arm of Merck KGaA distributing reagents, antibodies, lab consumables, and bioprocessing products with significant direct presence in France. Overlaps with Ozyme's molecular biology, cell culture, and antibody offerings but operates at much larger scale with proprietary product lines.
  • Thermo Fisher Scientific: Largest global life sciences tools and reagents provider with direct sales and distribution of antibodies, molecular biology reagents, cell culture, and lab equipment across France. Competes with Ozyme across nearly every category but as part of a much broader portfolio.
  • Avantor (VWR): Global laboratory products and services distributor (formerly VWR) serving research, pharma, and academic customers across Europe, including France. Comparable distribution model and customer base but vastly broader catalog spanning chemicals, consumables, equipment, and life sciences.

Regional players

  • Clinisciences: French life sciences distributor of reagents, antibodies, and cell biology products for research and clinical markets. Comparable business model and customer base to Ozyme, focused on the French-speaking research community.

Emerging players

  • Cell Signaling Technology (CST): US-based antibody and reagent developer that Ozyme distributes in France. Comparable as a specialized antibody supplier with strong presence in signaling pathway research; an upstream supplier to Ozyme but also a competitor when end users buy direct.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key highlights7 records

Customer concentration

Ozyme social profiles

Digital presence

Ozyme financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Ozyme leadership team

Management profile

Number of profiles

Ozyme funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Ozyme M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Ozyme

What does Ozyme do?

Ozyme is a specialty distributor of laboratory products for life sciences research in France, supplying research laboratories with antibodies, molecular biology reagents, cell culture consumables, and laboratory equipment sourced from leading manufacturers such as Cell Signaling Technology, Illumina, Corning, and Standard BioTools. The company offers its own OWIBIO molecular biology bioreagent line and provides technical support, 24-hour express delivery, equipment installation, and maintenance services alongside product sales.

Is Ozyme a public or private company?

Ozyme is a private company. It is classified as corporate owned and is currently operating.

When was Ozyme founded?

Ozyme was founded in 1984. It employs 11 to 50 people.

Where is Ozyme based?

Ozyme is headquartered in Saint-cyr-l'ecole, France, in the Europe region.

How does Ozyme make money?

One revenue line is on record: laboratory Products Distribution.

Who are Ozyme's main competitors?

Direct peers on record are Tebu-bio, Carl Roth and Dominique Dutscher. Broad incumbents are Abcam (Danaher), Bio-Techne, Merck Life Science (MilliporeSigma), Thermo Fisher Scientific and Avantor (VWR). Clinisciences is listed as a regional player. Cell Signaling Technology (CST) is listed as an emerging player.

Does Ozyme have an API?

No public API is recorded for Ozyme.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals